Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
NVIDIA Investing In Tiny Robotics Firm, Should You Follow?
NVIDIA gets a lot of attention for designing some of the world’s most powerful GPUs. It’s difficult to imagine that the recent advancements in artificial intelligence would have happened without NVIDIA. After all, OpenAI trained ChatGPT with 10,000 NVIDIA GPUs connected to a Microsoft supercomputer.
But NVIDIA actually does much more than build efficient processing units.
» Read more about: NVIDIA Investing In Tiny Robotics Firm, Should You Follow? »
Read More
Is Michael Saylor’s Bet Crazy: Bull vs Bear
Microstrategy (NASDAQ:MSTR) and its CEO Michael Saylor are in large part confounding valuation experts worldwide.
The traditional method of valuing a company goes something like this. Analyze the cash flows a company will produce over its lifetime, discount them back to present day, sum them up and arrive at a fair market valuation for the company.
» Read more about: Is Michael Saylor’s Bet Crazy: Bull vs Bear »
Read More
Why Did NVIDIA Invest In Little-Known AI Stock?
For nearly two years, the stock market has been steadily bidding up companies like NVIDIA and Microsoft that have emerged as front-runners in the AI race. In addition to these mega-cap companies, though, there are also many smaller companies trying to fill niche spaces in the AI market.
One such company is Nebius Group (NASDAQ:NBIS),
» Read more about: Why Did NVIDIA Invest In Little-Known AI Stock? »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
2 Billionaires Buy This Former Out-Of-Favor Bank, Why?
As recently as 2020, few analysts could have predicted that Stanley Druckenmiller, a billionaire who used to manage Quantum Fund with George Soros, would invest in Citigroup, a multinational banking company with a reputation for mismanaging funds and contributing to the Great Recession.
Despite those facts, Druckenmiller’s firm, Duquesne Family Office, bought more than 327,000 shares in Citigroup last quarter.
» Read more about: 2 Billionaires Buy This Former Out-Of-Favor Bank, Why? »
Read MoreThe Spotlight
Will Costco Finally Split Its Sky High Stock?
Costco’s stock price has experienced enormous growth over the last few years. At the beginning of 2020, you could purchase a share for a little less than $300. Today, shares trade for closer to $1,000.
Not surprisingly, this growth has encouraged a lot of analysts to speculate about when Costco will split its shares.
» Read more about: Will Costco Finally Split Its Sky High Stock? »
Read MoreThe Daily
Nvidia ETFs Plummet as New AI Rival Emerges: A Market Shockwave
Exchange-traded funds (ETFs) heavily invested in Nvidia suffered a sharp decline in early trading hours on Monday, sparked by the release of a new artificial intelligence model from a Chinese startup. Technology insiders are calling this development a “Sputnik moment” for U.S. AI companies, with downloads of the year-old DeepSeek model already surpassing those of American rival ChatGPT on Apple’s app store.
» Read more about: Nvidia ETFs Plummet as New AI Rival Emerges: A Market Shockwave »